Intellia Therapeutics, Inc. (NTLA)
NASDAQ·Healthcare·Biotechnology
$16.21
+11.37%
Mkt Cap $1.37B
Analyst Ratings
Buy
12
Hold
5
Sell
1
Price Target (50 analysts)
$20.88
Range $8.00 – $35.00
Implied Upside
+28.8%
Consensus $20.88 vs current $16.21
NASDAQ·Healthcare·Biotechnology
$16.21
+11.37%
Mkt Cap $1.37B
Buy
12
Hold
5
Sell
1
Price Target (50 analysts)
$20.88
Range $8.00 – $35.00
+28.8%
Consensus $20.88 vs current $16.21